Local recurrence of malignant tumor of urinary bladder (disorder)
BL-13
Year Started: 2019
A randomised phase II trial assessing trimodality therapy with or without adjuvant durvalumab to treat patients with muscle-invasive bladder cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
Biomarker datasets |
> 6 months |
Clinical records |
> 6 months |
Followup records |
> 6 months |
Freezer temperature logs |
> 6 months |
Genomic datasets |
> 6 months |
Physiological/biochemical measurements |
> 6 months |
Treatment records |
> 6 months |
Psychological data |
> 6 months |
Donor Ethnicity |
> 6 months |
Female
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Buffy coat |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
cDNA/mRNA |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Male
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Buffy coat |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
cDNA/mRNA |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Female
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Buffy coat |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
cDNA/mRNA |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Male
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Buffy coat |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
cDNA/mRNA |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
75% -99% |